Progesterone is often described as a calming hormone. In many women, it promotes sleep, relaxation, and emotional steadiness.
So why do some women experience intense anxiety, irritability, depression, or emotional volatility when progesterone rises?
The answer lies not in progesterone itself — but in how the brain responds to its metabolite: allopregnanolone (ALLO).
Understanding ALLO helps explain PMDD, perimenopausal mood changes, and why symptoms can occur even when hormone levels are completely normal.
Allopregnanolone (ALLO) is a neurosteroid made when the body metabolizes progesterone.
ALLO acts directly on GABA-A receptors, the brain’s primary inhibitory (calming) system — the same system targeted by medications like benzodiazepines.
In theory:
For many women, this pathway works beautifully.
But for others, it doesn’t.
Landmark research from the NIH has shown that women with PMDD have normal estrogen and progesterone levels.
What’s different is how their brains respond to hormonal change.
In experimental studies, when ovarian hormones were completely suppressed, PMDD symptoms disappeared.
When estrogen and progesterone were added back — at normal physiologic levels — symptoms returned rapidly.
This proves the issue is not too much or too little hormone.
It’s neurobiological sensitivity to fluctuation.
In hormone-sensitive brains, rapid changes in ALLO can destabilize GABA-A receptors instead of calming them.
This can result in:
Rather than soothing the nervous system, ALLO’s rise and fall becomes activating.
This is why PMDD symptoms often:
This same mechanism helps explain perimenopausal mood changes.
During perimenopause:
Some cycles have:
These “loop cycles” cause repeated ALLO rises and crashes — reactivating the same brain circuitry seen in PMDD.
This is why many women say:
“I haven’t felt this way since my worst PMS — but now it lasts all month.”
ALLO is:
A blood test can show:
…and still completely miss what the brain is experiencing.
This is why symptom patterns matter more than lab values when assessing hormonally driven mood changes.
SSRIs are uniquely effective in PMDD — often at:
Why?
Because SSRIs:
They don’t just treat mood — they help stabilize the brain’s response to hormonal change.
Effective treatment focuses on reducing hormonal volatility and supporting neurochemical stability.
This may include:
The goal isn’t to eliminate hormonal changes— it’s to help the brain stop overreacting to them.
If your mood shifts feel sudden, intense, and hormonally timed — your experience is real, biological, and treatable.
Listening to symptoms with curiosity — not dismissal — is often the first step toward real relief.
For some women, it’s not progesterone itself—it’s how the brain responds to its metabolite, allopregnanolone (ALLO). Instead of calming the nervous system, ALLO can destabilize GABA receptors, leading to anxiety, irritability, or mood swings.
Allopregnanolone is a neurosteroid made from progesterone that affects GABA-A receptors—the brain’s main calming system. In sensitive individuals, fluctuations in ALLO can trigger mood symptoms instead of relieving them.
Research shows that women with PMDD have normal hormone levels, but increased brain sensitivity to hormonal changes. Symptoms are caused by how the brain responds to fluctuations—not by too much or too little hormone.
During the luteal phase, progesterone rises and then drops quickly before menstruation. This drop causes a rapid change in ALLO levels, which can destabilize mood. Once hormone levels reset, symptoms often resolve quickly.
In perimenopause, ovulation becomes inconsistent and progesterone exposure becomes unpredictable. This leads to repeated rises and drops in ALLO, activating the same brain pathways seen in PMDD—but less predictably and often more persistently.
ALLO is not routinely measured and fluctuates rapidly. Standard hormone labs may appear normal even when the brain is experiencing significant instability.
SSRIs not only affect serotonin—they also modulate GABA-A receptor sensitivity and indirectly stabilize ALLO signaling. This is why they often work faster and at lower doses in PMDD compared to depression.
Not necessarily. Some people tolerate progesterone well, while others are more sensitive to ALLO fluctuations. The goal is not to avoid progesterone entirely, but to find the right formulation, dosing, and overall treatment approach.
For PMDD, Does Symptom-Onset Dosing of an SSRI Work?
PMDD Treatment with Serotonin Reuptake Inhibitors: Neuroactive Steroids and GABA May Play a Role
Conscious Psychiatry provides psychiatric medication management and hormone-informed mental health care for women in Denver and throughout Colorado. We specialize in anxiety, depression, PMDD, OCD, perimenopause and perinatal related mood symptoms using an evidence-based, individualized approach.
If you’re unsure whether your symptoms are hormonal, psychiatric, or both, we can help you determine the right treatment plan.
In-Person in Denver | Virtually Throughout Colorado and Oregon
Address: 950 S Cherry St Suite 1675, Denver, CO 80246
